JPRN-UMIN000010510
Completed
Phase 2
Phase II clinical trial of hypofractionated radiotherapy using proton beams for prostate cancer - Hypofractionated proton therapy for prostate cancer
Proton Medical Research Center, University of Tsukuba0 sites102 target enrollmentApril 16, 2013
ConditionsProstate cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Prostate cancer
- Sponsor
- Proton Medical Research Center, University of Tsukuba
- Enrollment
- 102
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who 1\) have lymph node metastasis 2\) have distant metastasis 3\) severe comcomitant diseases such as active infection, heart failure and myocardial infarction, severe respiratory dysfunction, renal faiure, and uncotrolled diabetes mellitus
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Phase II trial of hypofractionated intensity modulated radiotherapy in patients with low risk prostate cancerProstate cancerJPRN-UMIN000022570Kitasato university55
Completed
Not Applicable
Phase I/II clinical trial of hypofractionated image-guided proton therapy for prostate cancerlocalized prostate cancerJPRN-UMIN000038279agoya City University West Medical Center300
Active, not recruiting
Not Applicable
Phase II study of hypofractionated radio-chemotherapy with gemcitabine plus oxaliplatin for unresectable nonmetastatic locally advanced pancreatic cancer. - IRST 157.01EUCTR2010-020379-22-ITISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI
Completed
Phase 2
Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before SurgeryAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Prognostic Stage I Breast Cancer AJCC v8Prognostic Stage IA Breast Cancer AJCC v8Prognostic Stage IB Breast Cancer AJCC v8Prognostic Stage IIA Breast Cancer AJCC v8NCT03624478Mayo Clinic25
Recruiting
Phase 3
Phase III trial of hypo-fractionated accelerated intensity modulated radiotherapy with concurrent and maintenance temozolomide in newly diagnosed Glioblastoma (HYART-GBM)Health Condition 1: C719- Malignant neoplasm of brain, unspecifiedCTRI/2020/06/025573AIIMS New Delhi